Mission
Cellular Rejuvenation: Once a Dream, Now Our Mission
Aging is a process accompanied by progressive decline in cellular function. Our aim is to create a groundbreaking therapy based on patented proteins, that rejuvenate elderly cells, all while maintaining their distinct properties.
- innovative research
Introduction
Ananda Labs, Inc. is a US startup headquartered in New York City with an office in Tel-Aviv, and plans to open another office in Orange County, California. Established in 2023, the company has developed the RPER platform, based on 10 years of research at the Hebrew University of Jerusalem. This innovative, state-of-the-art platform uses patented factors to reverse aging by 50% and impact longevity.
Ananda Labs focuses on innovative research and development and is planning to raise funds to disrupt the world of medicine, aiming to cure diseases and conditions that have had no solutions or only symptomatic treatments until now. We offer an exceptional opportunity for accredited investors to participate. The company is a subsidiary of Onassis Holdings Corp, a Nevada-based company. The company is managed by a skilled team in science, medicine, and finance.
- science
Impactful Publications
Our technology was developed based on extensive scientific research published in prestigious, high-impact journals from the Nature, Science, and Cell publishing groups.
Mission
Our Invention
Overview
Ananda Labs Inc. is at the forefront of epigenetic reprogramming for longevity and anti-aging, developed in partnership with the Hebrew University of Jerusalem.
Ananda Labs is creating advanced therapeutics centered on epigenetic reprogramming to combat human diseases and promote anti-aging.
This involves altering gene expression without changing the DNA sequence, using epigenetic editors—a potentially revolutionary advancement in the medical and wellness industry.
Competitive Advantage
Ananda Labs has a superior and safer set of patented factors compared to competitors, providing a significant advantage. Competitors’ valuations range from hundreds of millions to a few billion dollars, all being in the R&D stage.
Patents
Onassis and Ananda Labs hold exclusive licensing rights to several key patents, including the method for reprogramming human cells.
Mission
Vision and Values
Skin damage
Wrinkles
Reversing White Hair
Scars
Hair loss
younger appearance
Mission in Dermal Treatments
We aim to rejuvenate fibroblast cells by 40%-50% of their age to provide long-lasting skin elasticity and a healthy, younger appearance. Our research will focus on:
Short term goal
- Wrinkles
- Skin damage
- Scars
Long term goal
- Hair loss
- Reversing white hair
Eyes
Improving the Immune System
- Privacy Policy
- Terms of Service